Connor, Clark & Lunn Investment Management (CC&L)’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,275
Closed -$125K 1683
2025
Q4
$125K Sell
20,275
-17,885
-47% -$132K ﹤0.01% 1472
2025
Q3
$371K Sell
38,160
-21,810
-36% -$273K ﹤0.01% 1315
2025
Q2
$784K Buy
+59,970
New +$775K ﹤0.01% 1124
2024
Q2
Sell
-15,296
Closed -$92.5K 1541
2024
Q1
$92.5K Buy
15,296
+5,126
+50% +$32.4K ﹤0.01% 1470
2023
Q4
$61K Buy
+10,170
New +$67.2K ﹤0.01% 1335
2022
Q3
Sell
-34,377
Closed -$150K 1185
2022
Q2
$150K Sell
34,377
-10,294
-23% -$44.9K ﹤0.01% 957
2022
Q1
$213K Sell
44,671
-8,487
-16% -$47.1K ﹤0.01% 930
2021
Q4
$336K Sell
53,158
-631
-1% -$4.29K ﹤0.01% 868
2021
Q3
$364K Sell
53,789
-454
-0.8% -$3.34K ﹤0.01% 833
2021
Q2
$399K Buy
54,243
+3
+0% +$24 ﹤0.01% 825
2021
Q1
$507K Buy
54,240
+750
+1% +$7K ﹤0.01% 792
2020
Q4
$499K Sell
53,490
-1,787
-3% -$20.1K ﹤0.01% 725
2020
Q3
$667K Buy
55,277
+5,255
+11% +$71K ﹤0.01% 691
2020
Q2
$676K Sell
50,022
-4,307
-8% -$59.7K ﹤0.01% 695
2020
Q1
$560K Buy
54,329
+14,250
+36% +$195K 0.01% 667
2019
Q4
$626K Sell
40,079
-4,425
-10% -$65.1K ﹤0.01% 623
2019
Q3
$610K Sell
44,504
-1,600
-3% -$19.5K ﹤0.01% 637
2019
Q2
$598K Buy
46,104
+8,175
+22% +$97.2K ﹤0.01% 682
2019
Q1
$542K Sell
37,929
-2,945
-7% -$42.8K ﹤0.01% 652
2018
Q4
$539K Buy
40,874
+5,125
+14% +$61.3K ﹤0.01% 680
2018
Q3
$393K Buy
+35,749
New +$381K ﹤0.01% 741
2017
Q3
Sell
-28,275
Closed -$122K 872
2017
Q2
$122K Sell
28,275
-1,500
-5% -$6.61K ﹤0.01% 780
2017
Q1
$160K Buy
29,775
+5,450
+22% +$34.4K ﹤0.01% 819
2016
Q4
$198K Sell
24,325
-1,900
-7% -$16.2K ﹤0.01% 790
2016
Q3
$248K Sell
26,225
-2,900
-10% -$37.7K ﹤0.01% 705
2016
Q2
$396K Buy
29,125
+1,600
+6% +$18.2K ﹤0.01% 628
2016
Q1
$250K Buy
27,525
+11,500
+72% +$102K ﹤0.01% 683
2015
Q4
$153K Buy
+16,025
New +$121K ﹤0.01% 725

Other funds holding LFVN

Connor, Clark & Lunn Investment Management (CC&L)'s LFVN Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of LifeVantage (LFVN) in Q1 2026, closing a stake of 20,275 shares — an estimated $125K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LFVN in Q4 2015 and held it in 28 quarters. The position peaked at $784K in Q2 2025. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining LifeVantage position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 20,275 LifeVantage shares in Q1 2026, an estimated $125K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LifeVantage in Q4 2015 and held it in 28 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s LifeVantage position peaked at $784K in Q2 2025.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.